ArticleJournal of medical case reports2025
Classic multivisceral transplant for advanced nonresectable pseudomyxoma peritonei: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress in the diagnosis and treatment of pseudomyxoma peritonei.World journal of surgical oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPseudomyxoma peritonei is uncommon with a poorly understood pathogenesis. The standard treatment is cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. However, radical surgical resection is not feasible for patients with extensive unresectable disease, which can lead to bowel obstruction, nutritional failure, and potentially death. In this report, we recommend classic multivisceral transplant as a potential curative treatment for advanced, unresectable pseudomyxoma peritonei, an application that, to our knowledge, has not been previously described. CASE PRESENTATION: We describe the case of a 34-year-old Iranian man with pseudomyxoma peritonei who presented with abdominal distension and weight loss. He initially underwent incomplete cytoreductive surgery due to extent of the disease. Subsequently, due to progressive disease and development of intestinal failure, he underwent a successful extraperitoneal radical exenteration and classic multivisceral transplant. No disease recurrence or significant postoperative complications were observed during 1.5 years of follow-up.
conclusionThis case presentation demonstrates that total extraperitoneal radical exenteration followed by classic multivisceral transplant can be a viable and effective treatment option for patients with inoperable pseudomyxoma peritonei complicated by intestinal failure. It offers significant benefits to patients, improving both quality of life and life expectancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.